myrrha (commiphora myrrha)

Botanicalexperimental

Clinical trial activity

3 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0

Earliest trial started Dec 1, 2011 (NCT01529710)

Timeline

2010s

  1. Jan 1, 2011

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • bola resin
  • commiphora molmol resin
  • commiphora myrrha gum resin
  • commiphora myrrha resin
  • commiphora myrrha resin extract
  • common myrrh
  • hirabol myrrh
  • mo yao
  • moyao (commiphora molmol)
  • moyao (commiphora myrrha)
  • myrrh
  • myrrh
  • myrrh
  • myrrh
  • myrrha
  • myrrha (commiphora molmol)
  • myrrha (commiphora myrrha)
  • myrrh (commiphora molmol)
  • myrrh (commiphora myrrha)

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04494165N/AJul 1, 2019Erciyes University
NCT04723732N/AAug 15, 2017King Abdul-Aziz University
NCT01529710Phase 3Dec 1, 2011Government of Netherlands, Pharco Pharmaceuticals
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Erciyes UniversityAcademic/Hospital1112019
Government of NetherlandsGovernment1012011
King Abdul-Aziz UniversityAcademic/Hospital1112017
Pharco PharmaceuticalsFor profit1112011
4 organizations
Page 1 / 1